These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 29575299)
1. The PLGF/c-MYC/miR-19a axis promotes metastasis and stemness in gallbladder cancer. Li H; Jin Y; Hu Y; Jiang L; Liu F; Zhang Y; Hao Y; Chen S; Wu X; Liu Y Cancer Sci; 2018 May; 109(5):1532-1544. PubMed ID: 29575299 [TBL] [Abstract][Full Text] [Related]
2. miR-101 targeting ZFX suppresses tumor proliferation and metastasis by regulating the MAPK/Erk and Smad pathways in gallbladder carcinoma. Bao RF; Shu YJ; Hu YP; Wang XA; Zhang F; Liang HB; Ye YY; Li HF; Xiang SS; Weng H; Cao Y; Wu XS; Li ML; Wu WG; Zhang YJ; Jiang L; Dong Q; Liu YB Oncotarget; 2016 Apr; 7(16):22339-54. PubMed ID: 26968949 [TBL] [Abstract][Full Text] [Related]
3. MiR-143-5p Deficiency Triggers EMT and Metastasis by Targeting HIF-1α in Gallbladder Cancer. He M; Zhan M; Chen W; Xu S; Long M; Shen H; Shi Y; Liu Q; Mohan M; Wang J Cell Physiol Biochem; 2017; 42(5):2078-2092. PubMed ID: 28803245 [TBL] [Abstract][Full Text] [Related]
4. MiR-20a triggers metastasis of gallbladder carcinoma. Chang Y; Liu C; Yang J; Liu G; Feng F; Tang J; Hu L; Li L; Jiang F; Chen C; Wang R; Yang Y; Jiang X; Wu M; Chen L; Wang H J Hepatol; 2013 Sep; 59(3):518-27. PubMed ID: 23665284 [TBL] [Abstract][Full Text] [Related]
5. miR-143-3p targeting of ITGA6 suppresses tumour growth and angiogenesis by downregulating PLGF expression via the PI3K/AKT pathway in gallbladder carcinoma. Jin YP; Hu YP; Wu XS; Wu YS; Ye YY; Li HF; Liu YC; Jiang L; Liu FT; Zhang YJ; Hao YJ; Liu XY; Liu YB Cell Death Dis; 2018 Feb; 9(2):182. PubMed ID: 29416013 [TBL] [Abstract][Full Text] [Related]
6. Loss of NDRG2 promotes epithelial-mesenchymal transition of gallbladder carcinoma cells through MMP-19-mediated Slug expression. Lee DG; Lee SH; Kim JS; Park J; Cho YL; Kim KS; Jo DY; Song IC; Kim N; Yun HJ; Park YJ; Lee SJ; Lee HG; Bae KH; Lee SC; Shim S; Kim YM; Kwon YG; Kim JM; Lee HJ; Min JK J Hepatol; 2015 Dec; 63(6):1429-39. PubMed ID: 26292259 [TBL] [Abstract][Full Text] [Related]
7. Ring finger protein 125, as a potential highly aggressive and unfavorable prognostic biomarker, promotes the invasion and metastasis of human gallbladder cancers via activating the TGF- β1-SMAD3-ID1 signaling pathway. Liu ZY; Cao J; Zhang JT; Xu GL; Li XP; Wang FT; Ansari KH; Mohamed H; Fan YZ Oncotarget; 2017 Jul; 8(30):49897-49914. PubMed ID: 28611292 [TBL] [Abstract][Full Text] [Related]
8. The microRNA miR-33a suppresses IL-6-induced tumor progression by binding Twist in gallbladder cancer. Zhang M; Gong W; Zuo B; Chu B; Tang Z; Zhang Y; Yang Y; Zhou D; Weng M; Qin Y; Ma M; Jiang A; Ma F; Quan Z Oncotarget; 2016 Nov; 7(48):78640-78652. PubMed ID: 27769047 [TBL] [Abstract][Full Text] [Related]
9. PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway. Shen H; He M; Lin R; Zhan M; Xu S; Huang X; Xu C; Chen W; Yao Y; Mohan M; Wang J J Exp Clin Cancer Res; 2019 Jun; 38(1):247. PubMed ID: 31182136 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-30a-5p inhibits gallbladder cancer cell proliferation, migration and metastasis by targeting E2F7. Ye YY; Mei JW; Xiang SS; Li HF; Ma Q; Song XL; Wang Z; Zhang YC; Liu YC; Jin YP; Hu YP; Jiang L; Liu FT; Zhang YJ; Hao YJ; Liu YB Cell Death Dis; 2018 Mar; 9(3):410. PubMed ID: 29540696 [TBL] [Abstract][Full Text] [Related]
11. Up-regulated microRNA-33b inhibits epithelial-mesenchymal transition in gallbladder cancer through down-regulating CROCC. Xu G; Wei X; Tu Q; Zhou C Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31799620 [TBL] [Abstract][Full Text] [Related]
12. The microRNA cluster miR-214/miR-3120 prevents tumor cell switching from an epithelial to a mesenchymal-like phenotype and inhibits autophagy in gallbladder cancer. Li W; Yan P; Meng X; Zhang J; Yang Y Cell Signal; 2021 Apr; 80():109887. PubMed ID: 33340658 [TBL] [Abstract][Full Text] [Related]
13. Targeting of NT5E by miR-30b and miR-340 attenuates proliferation, invasion and migration of gallbladder carcinoma. Wang N; Xiang X; Chen K; Liu P; Zhu A Biochimie; 2018 Mar; 146():56-67. PubMed ID: 29155108 [TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA TUG1 promotes cell proliferation and metastasis by negatively regulating miR-300 in gallbladder carcinoma. Ma F; Wang SH; Cai Q; Jin LY; Zhou D; Ding J; Quan ZW Biomed Pharmacother; 2017 Apr; 88():863-869. PubMed ID: 28178615 [TBL] [Abstract][Full Text] [Related]
15. Roles of Pin1 as a Key Molecule for EMT Induction by Activation of STAT3 and NF-κB in Human Gallbladder Cancer. Nakada S; Kuboki S; Nojima H; Yoshitomi H; Furukawa K; Takayashiki T; Takano S; Miyazaki M; Ohtsuka M Ann Surg Oncol; 2019 Mar; 26(3):907-917. PubMed ID: 30610554 [TBL] [Abstract][Full Text] [Related]
16. miR-324-5p inhibits gallbladder carcinoma cell metastatic behaviours by downregulation of transforming growth factor beta 2 expression. Zhang X; Zhang L; Chen M; Liu D Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):315-324. PubMed ID: 31858815 [TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA MINCR promotes gallbladder cancer progression through stimulating EZH2 expression. Wang SH; Yang Y; Wu XC; Zhang MD; Weng MZ; Zhou D; Wang JD; Quan ZW Cancer Lett; 2016 Sep; 380(1):122-33. PubMed ID: 27345740 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of LncRNA AFAP1-AS1 predicts poor prognosis and promotes cells proliferation and invasion in gallbladder cancer. Ma F; Wang SH; Cai Q; Zhang MD; Yang Y; Ding J Biomed Pharmacother; 2016 Dec; 84():1249-1255. PubMed ID: 27810781 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-29c-5p suppresses gallbladder carcinoma progression by directly targeting CPEB4 and inhibiting the MAPK pathway. Shu YJ; Bao RF; Jiang L; Wang Z; Wang XA; Zhang F; Liang HB; Li HF; Ye YY; Xiang SS; Weng H; Wu XS; Li ML; Hu YP; Lu W; Zhang YJ; Zhu J; Dong P; Liu YB Cell Death Differ; 2017 Mar; 24(3):445-457. PubMed ID: 28060377 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma. Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]